Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Henoch S,Hong

第一单位： CureVac AG , Tübingen, Germany.

作者： Henoch S,Hong ^[1] ; Sven D,Koch ^[1] ; Birgit,Scheel ^[1] ; Ulrike,Gnad-Vogt ^[1] ; Andreas,Schröder ^[1] ; Karl-Josef,Kallen ^[1] ; Volker,Wiegand ^[1] ; Linus,Backert ^[2] ; Oliver,Kohlbacher ^[3] ; Ingmar,Hoerr ^[1] ; Mariola,Fotin-Mleczek ^[1] ; James M,Billingsley ^[4]

作者单位： CureVac AG , Tübingen, Germany. ^[1] Center for Bioinformatics and Center for Bioinformatics, University of Tübingen , Germany. ^[2] Center for Bioinformatics and Center for Bioinformatics, University of Tübingen, Germany; Quantitative Biology Center, University of Tübingen, Germany; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany. ^[3] Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough , MA, USA. ^[4]

关键词 Biomarker candidates NSCLC cancer immunotherapy mRNA-based vaccines systems immunology transcriptomics

DOI 10.1080/2162402X.2016.1249560

PMID 28123889

发布时间 2021-01-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览40

Oncoimmunology

e1249560页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.

Oncoimmunology

相似文献

Oncoimmunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.

Oncoimmunology

相似文献

Oncoimmunology

相关期刊

检索历史清除